Synapsoft logo
AI Insights from Disclosures
Searching...
DuChemBio Co, LTD 176750
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
DuChemBio Co, LTD was established as a company specializing in the development, manufacture, and sale of radiopharmaceuticals for the diagnosis and treatment of cancer and brain diseases, and it operates its business on the basis of a stable pharmaceutical supply chain, holding the largest number of PET-CT radiopharmaceutical items in Korea and operating the largest number of manufacturing sites in Korea, 12 in total, including six GMP-certified pharmaceutical manufacturing sites. Radiopharmaceuticals, the business the company operates, are pharmaceuticals under the Pharmaceutical Affairs Act composed of radioactive isotopes that emit radiation and drugs (compounds, antibodies, peptides, etc.) that carry the radioactive isotopes to the diseased area.
Representative Director Kim Sangu
Founded November 6, 2002
Corporation Type KOSDAQ
Industry Classification Manufacture of synthetic drug and other finished medicaments
Corporate number 11011-2647604
Business number 105-86-50172
Phone Number 02-332-4868
Fax Number 02)332-4768
Company Address 81 Wausan-ro, Mapo-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant